BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 29363426)

  • 1. A novel algorithm for finding optimal driver nodes to target control complex networks and its applications for drug targets identification.
    Guo WF; Zhang SW; Shi QQ; Zhang CM; Zeng T; Chen L
    BMC Genomics; 2018 Jan; 19(Suppl 1):924. PubMed ID: 29363426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the number of driver nodes for controlling a Boolean network when the targets are restricted to attractors.
    Hou W; Ruan P; Ching WK; Akutsu T
    J Theor Biol; 2019 Feb; 463():1-11. PubMed ID: 30543810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting drug targets with minimum side effects in metabolic networks.
    Li Z; Wang RS; Zhang XS; Chen L
    IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
    Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
    J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target controllability with minimal mediators in complex biological networks.
    Ebrahimi A; Nowzari-Dalini A; Jalili M; Masoudi-Nejad A
    Genomics; 2020 Nov; 112(6):4938-4944. PubMed ID: 32905831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
    Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
    Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network output controllability-based method for drug target identification.
    Wu L; Shen Y; Li M; Wu FX
    IEEE Trans Nanobioscience; 2015 Mar; 14(2):184-91. PubMed ID: 25643411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Boolean modeling of biological networks applied to systems pharmacology.
    Irurzun-Arana I; Pastor JM; Trocóniz IF; Gómez-Mantilla JD
    Bioinformatics; 2017 Apr; 33(7):1040-1048. PubMed ID: 28073755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel network control model for identifying personalized driver genes in cancer.
    Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
    PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A constrained evolutionary computation method for detecting controlling regions of cortical networks.
    Tang Y; Wang Z; Gao H; Swift S; Kurths J
    IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(6):1569-81. PubMed ID: 23221081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Network Inference and analysis using SEBINI and CABIN.
    Taylor R; Singhal M
    Methods Mol Biol; 2009; 541():551-76. PubMed ID: 19381531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controllability in cancer metabolic networks according to drug targets as driver nodes.
    Asgari Y; Salehzadeh-Yazdi A; Schreiber F; Masoudi-Nejad A
    PLoS One; 2013; 8(11):e79397. PubMed ID: 24282504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering driver nodes in chronic kidney disease-related networks using Trader as a newly developed algorithm.
    Masoudi-Sobhanzadeh Y; Gholaminejad A; Gheisari Y; Roointan A
    Comput Biol Med; 2022 Sep; 148():105892. PubMed ID: 35932730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining minimum set of driver nodes in protein-protein interaction networks.
    Zhang XF; Ou-Yang L; Zhu Y; Wu MY; Dai DQ
    BMC Bioinformatics; 2015 May; 16():146. PubMed ID: 25947063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of multilayer biological networks and applied to target identification of complex diseases.
    Zheng W; Wang D; Zou X
    BMC Bioinformatics; 2019 May; 20(1):271. PubMed ID: 31138124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CytoCtrlAnalyser: a Cytoscape app for biomolecular network controllability analysis.
    Wu L; Li M; Wang J; Wu FX
    Bioinformatics; 2018 Apr; 34(8):1428-1430. PubMed ID: 29186337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression complex networks: synthesis, identification, and analysis.
    Lopes FM; Cesar RM; Costa Lda F
    J Comput Biol; 2011 Oct; 18(10):1353-67. PubMed ID: 21548810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of complex signaling networks to a representative kernel.
    Kim JR; Kim J; Kwon YK; Lee HY; Heslop-Harrison P; Cho KH
    Sci Signal; 2011 May; 4(175):ra35. PubMed ID: 21632468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Boolean metabolic networks: integer linear programming based approach.
    Qiu Y; Jiang H; Ching WK; Cheng X
    BMC Syst Biol; 2018 Apr; 12(Suppl 1):7. PubMed ID: 29671395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.